These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 16735941

  • 41. Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo-controlled study.
    D'Anna R, Cannata ML, Marini H, Atteritano M, Cancellieri F, Corrado F, Triolo O, Rizzo P, Russo S, Gaudio A, Frisina N, Bitto A, Polito F, Minutoli L, Altavilla D, Adamo EB, Squadrito F.
    Menopause; 2009; 16(2):301-6. PubMed ID: 19034051
    [Abstract] [Full Text] [Related]

  • 42. Transdermal estradiol gel for the treatment of symptomatic postmenopausal women.
    Archer DF, Pickar JH, MacAllister DC, Warren MP.
    Menopause; 2012 Jun; 19(6):622-9. PubMed ID: 22282101
    [Abstract] [Full Text] [Related]

  • 43. Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative.
    Barnabei VM, Cochrane BB, Aragaki AK, Nygaard I, Williams RS, McGovern PG, Young RL, Wells EC, O'Sullivan MJ, Chen B, Schenken R, Johnson SR, Women's Health Initiative Investigators.
    Obstet Gynecol; 2005 May; 105(5 Pt 1):1063-73. PubMed ID: 15863546
    [Abstract] [Full Text] [Related]

  • 44. Vasomotor hot flashes and heart rate variability: a placebo-controlled trial of postmenopausal hormone therapy.
    Lantto H, Haapalahti P, Tuomikoski P, Viitasalo M, Väänänen H, Sovijärvi AR, Ylikorkala O, Mikkola TS.
    Menopause; 2012 Jan; 19(1):82-8. PubMed ID: 21934534
    [Abstract] [Full Text] [Related]

  • 45. [Continuous, low dosage estradiol administration with a vaginal ring: a placebo-controlled study].
    Casper F, Petri E, Benninghoff B.
    Zentralbl Gynakol; 1998 Jan; 120(9):449-53. PubMed ID: 9796090
    [Abstract] [Full Text] [Related]

  • 46. Validation of the Women's Health Initiative Insomnia Rating Scale in a multicenter controlled clinical trial.
    Levine DW, Dailey ME, Rockhill B, Tipping D, Naughton MJ, Shumaker SA.
    Psychosom Med; 2005 Jan; 67(1):98-104. PubMed ID: 15673630
    [Abstract] [Full Text] [Related]

  • 47. Desvenlafaxine for the treatment of vasomotor symptoms associated with menopause: a double-blind, randomized, placebo-controlled trial of efficacy and safety.
    Archer DF, Dupont CM, Constantine GD, Pickar JH, Olivier S, Study 319 Investigators.
    Am J Obstet Gynecol; 2009 Mar; 200(3):238.e1-238.e10. PubMed ID: 19167693
    [Abstract] [Full Text] [Related]

  • 48. Desvenlafaxine compared with placebo for treatment of menopausal vasomotor symptoms: a 12-week, multicenter, parallel-group, randomized, double-blind, placebo-controlled efficacy trial.
    Pinkerton JV, Constantine G, Hwang E, Cheng RF, Study 3353 Investigators.
    Menopause; 2013 Jan; 20(1):28-37. PubMed ID: 23010882
    [Abstract] [Full Text] [Related]

  • 49. A randomized, placebo- and active-controlled trial of bazedoxifene/conjugated estrogens for treatment of moderate to severe vulvar/vaginal atrophy in postmenopausal women.
    Kagan R, Williams RS, Pan K, Mirkin S, Pickar JH.
    Menopause; 2010 Mar; 17(2):281-9. PubMed ID: 19779382
    [Abstract] [Full Text] [Related]

  • 50. Randomized, multicenter, double-blind, placebo-controlled trial to evaluate the efficacy and safety of synthetic conjugated estrogens B for the treatment of vulvovaginal atrophy in healthy postmenopausal women.
    Simon JA, Reape KZ, Wininger S, Hait H.
    Fertil Steril; 2008 Oct; 90(4):1132-8. PubMed ID: 18053998
    [Abstract] [Full Text] [Related]

  • 51. Applied relaxation and oral estradiol treatment of vasomotor symptoms in postmenopausal women.
    Nedstrand E, Wijma K, Wyon Y, Hammar M.
    Maturitas; 2005 Jun 16; 51(2):154-62. PubMed ID: 15917156
    [Abstract] [Full Text] [Related]

  • 52. Frequency and severity of vasomotor symptoms among peri- and postmenopausal women in the United States.
    Williams RE, Kalilani L, DiBenedetti DB, Zhou X, Granger AL, Fehnel SE, Levine KB, Jordan J, Clark RV.
    Climacteric; 2008 Feb 16; 11(1):32-43. PubMed ID: 18202963
    [Abstract] [Full Text] [Related]

  • 53. Efficacy and tolerability of estradiol 1 mg and drospirenone 2 mg in postmenopausal Korean women: a double-blind, randomized, placebo-controlled, multicenter study.
    Lee BS, Kang BM, Yoon BK, Choi H, Park HM, Kim JG.
    Maturitas; 2007 Aug 20; 57(4):361-9. PubMed ID: 17467203
    [Abstract] [Full Text] [Related]

  • 54. Low-dose estradiol for climacteric symptoms in Japanese women: a randomized, controlled trial.
    Honjo H, Taketani Y.
    Climacteric; 2009 Aug 20; 12(4):319-28. PubMed ID: 19330598
    [Abstract] [Full Text] [Related]

  • 55. Effects of acupuncture on hot flashes in perimenopausal and postmenopausal women--a multicenter randomized clinical trial.
    Kim KH, Kang KW, Kim DI, Kim HJ, Yoon HM, Lee JM, Jeong JC, Lee MS, Jung HJ, Choi SM.
    Menopause; 2010 Mar 20; 17(2):269-80. PubMed ID: 19907348
    [Abstract] [Full Text] [Related]

  • 56. A short study in the treatment of hot flashes with buccal administration of 17-beta estradiol.
    Gass MS, Rebar RW, Cuffie-Jackson C, Cedars MI, Lobo RA, Shoupe D, Judd HL, Buyalos RP, Clisham PR.
    Maturitas; 2004 Oct 15; 49(2):140-7. PubMed ID: 15474758
    [Abstract] [Full Text] [Related]

  • 57. Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial.
    Bachmann G, Lobo RA, Gut R, Nachtigall L, Notelovitz M.
    Obstet Gynecol; 2008 Jan 15; 111(1):67-76. PubMed ID: 18165394
    [Abstract] [Full Text] [Related]

  • 58. A 17β-Estradiol-Progesterone Oral Capsule for Vasomotor Symptoms in Postmenopausal Women: A Randomized Controlled Trial.
    Lobo RA, Archer DF, Kagan R, Kaunitz AM, Constantine GD, Pickar JH, Graham S, Bernick B, Mirkin S.
    Obstet Gynecol; 2018 Jul 15; 132(1):161-170. PubMed ID: 29889748
    [Abstract] [Full Text] [Related]

  • 59. A comparison of raloxifene and calcium plus vitamin D on vaginal atrophy after discontinuation of long-standing postmenopausal hormone therapy in osteoporotic women. A randomized, masked-evaluator, one-year, prospective study.
    Checa MA, Garrido A, Prat M, Conangla M, Rueda C, Carreras R.
    Maturitas; 2005 Sep 16; 52(1):70-7. PubMed ID: 16143228
    [Abstract] [Full Text] [Related]

  • 60. Does hormone therapy improve age-related skin changes in postmenopausal women? A randomized, double-blind, double-dummy, placebo-controlled multicenter study assessing the effects of norethindrone acetate and ethinyl estradiol in the improvement of mild to moderate age-related skin changes in postmenopausal women.
    Phillips TJ, Symons J, Menon S, HT Study Group.
    J Am Acad Dermatol; 2008 Sep 16; 59(3):397-404.e3. PubMed ID: 18625536
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.